Sleep Apnea Diagnostics Market Overview:
The global sleep apnea diagnostics market was valued at $99million in 2017, and is expected to reach $168 million by 2025, registering a CAGR of 6.8% from 2018 to 2025.
Sleep apnea is a sleep disorder that fluctuates with the patient's breathing pattern. It may decrease or even stop patient's breathing completely during sleep. In few cases, it may pause the breathing (called apnea), which can last 10 seconds or longer and can occur 30 times or more in an hour. Symptoms of sleep apnea include daytime sleepiness, loud snoring, and restless sleep. Approximately 18 million Americans suffer from sleep apnea, while only 20% have been diagnosed and treated.
The major key factors that drive the growth of the sleep apnea diagnostics market include rise in sedentary lifestyle diseases such as diabetes & others and surge in geriatric population. Obesity is considered one of the major risk factor for the development and progression of sleep apnea. In addition, technological advancements to make products more comfortable for patients and considerable upsurge in sleep apnea disorders boost the growth of the global market. However, high cost associated with these devices, limited reimbursement of these devices, and low patient awareness regarding sleep apnea are projected to hinder the market growth. Moreover, increase in preference for home healthcare devices among patients is projected to create lucrative growth opportunities in the near future.
The global sleep apnea diagnostics market is segmented based on product and region. Based on product, the market is divided into polysomnography (PSG) device, actigraphy system, respiratory polygraph, sleep apnea screening device, and oximeter. Based on end user, the market is bifurcated into hospitals & sleep laboratories and home care settings. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Sleep Apnea Diagnostics Market:
The study provides an in-depth analysis of the global sleep apnea diagnostics market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Sleep Apnea Diagnostics Key Market Segments:
By Product
Polysomnography Device (PSG)
Clinical PSG Device
Ambulatory PSG Device
Sleep Apnea Screening Device
Actigraphy Monitoring Device
Respiratory Polygraph
Oximeter
Finger Tip Oximeter
Handheld Oximeter
Wrist-worn Oximeter
Tabletop Oximeter
Others
By End User
Hospitals & Sleep Laboratories
Home Care Settings
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
KEY MARKET PLAYERS
Cadwell Laboratories Inc.
DeVilbiss Healthcare LLC.
Koninklijke Philips N.V
Medtronic plc
Mindray
Natus Medical Incorporated
Nihon Kohden Corporation
Resmed
Smiths Medical
SomnoMedics
The other players in the value chain include (profiles not included in the report):
Cleveland Medical Devices, Inc.
Compumedics Ltd.
Fisher & Paykel Healthcare Limited
Vyaire Medical, Inc
Becton, Dickinson and Company
BMC Medical Co., Ltd
